Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations
Clinical trial NCT02100436 · COMPLETED
Trial details
- NCT number
- NCT02100436
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-11
- Primary completion
- 2015-03-20
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.